Literature DB >> 17627630

Hepatitis B virus genotypes in Europe.

Stephan Schaefer1.   

Abstract

There are eight genotypes of hepatitis B virus (HBV). Most genotypes can be further divided into subgenotypes. HBV genotypes influence the course of disease and treatment, and show geographic preferences. In Europe, A and D are the main genotypes found. Genotype A is more prevalent in northern Europe, where genotype D is mainly found in countries surrounding the Mediterranean Sea and in Eastern Europe. Subgenotype A2 is the dominant subgenotype in Europe, but the geographic prevalence of the four subgenotypes found in genotype D is not yet clear. On treatment with interferon HBV, genotype A, compared to genotype D, showsbetter virological response and in a large proportion of patients, even development of anti-HBs. However, in the first year of treatment with lamivudine, higher rates of emergence of YMDD variants are observed in genotype A. This work summarizes the current knowledge on HBV genotypes in countries with low and intermediate HBV carriership from Europe.

Entities:  

Year:  2007        PMID: 17627630     DOI: 10.1111/j.1872-034X.2007.00099.x

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  18 in total

Review 1.  [Sexually transmissible hepatitis viruses].

Authors:  S Schaefer
Journal:  Hautarzt       Date:  2009-06       Impact factor: 0.751

2.  Clinical relevance and public health significance of hepatitis B virus genomic variations.

Authors:  Guang-Wen Cao
Journal:  World J Gastroenterol       Date:  2009-12-14       Impact factor: 5.742

3.  The characteristics of the synonymous codon usage in hepatitis B virus and the effects of host on the virus in codon usage pattern.

Authors:  Ming-ren Ma; Xiao-qin Ha; Hui Ling; Mei-liang Wang; Fang-xin Zhang; Shang-di Zhang; Ge Li; Wei Yan
Journal:  Virol J       Date:  2011-12-15       Impact factor: 4.099

Review 4.  Hepatitis B virus burden in developing countries.

Authors:  Rosa Zampino; Adriana Boemio; Caterina Sagnelli; Loredana Alessio; Luigi Elio Adinolfi; Evangelista Sagnelli; Nicola Coppola
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

Review 5.  Clinical significance of hepatitis B surface antigen mutants.

Authors:  Nicola Coppola; Lorenzo Onorato; Carmine Minichini; Giovanni Di Caprio; Mario Starace; Caterina Sagnelli; Evangelista Sagnelli
Journal:  World J Hepatol       Date:  2015-11-28

Review 6.  Enigmatic origin of hepatitis B virus: an ancient travelling companion or a recent encounter?

Authors:  Gianguglielmo Zehender; Erika Ebranati; Elena Gabanelli; Chiara Sorrentino; Alessandra Lo Presti; Elisabetta Tanzi; Massimo Ciccozzi; Massimo Galli
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

7.  Spatial and temporal dynamics of hepatitis B virus D genotype in Europe and the Mediterranean Basin.

Authors:  Gianguglielmo Zehender; Erika Ebranati; Elena Gabanelli; Renata Shkjezi; Alessia Lai; Chiara Sorrentino; Alessandra Lo Presti; Mimoza Basho; Raffaele Bruno; Elisabetta Tanzi; Silvia Bino; Massimo Ciccozzi; Massimo Galli
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

8.  Molecular epidemiology of hepatitis B virus infection in Switzerland: a retrospective cohort study.

Authors:  Cédric Hirzel; Gilles Wandeler; Marta Owczarek; Meri Gorgievski-Hrisoho; Jean-Francois Dufour; Nasser Semmo; Samuel Zürcher
Journal:  BMC Infect Dis       Date:  2015-10-30       Impact factor: 3.090

9.  Mutations and CpG islands among hepatitis B virus genotypes in Europe.

Authors:  Chengyao Zhong; Zhiwei Hou; Jihua Huang; Qingdong Xie; Ying Zhong
Journal:  BMC Bioinformatics       Date:  2015-02-05       Impact factor: 3.169

10.  Characterization of Antigen Escape Mutations in Chronic HBV-Infected Patients in Upper Egypt.

Authors:  Mohamed A El-Mokhtar; Helal F Hetta; Mohamed A Mekky; Doaa M Abd El-Kareem; Mohammed Ramadan; Mohammed Salah; Nahed A Mohamed; Eman A El-Masry; Sara Adel; Ibrahim M Sayed
Journal:  Infect Drug Resist       Date:  2021-06-28       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.